Search

everythinglearnresearchcommunity

for

Search:↓

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

Hair changes can indicate systemic diseases or medication effects.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Understanding molecular pathways is key to improving organ regeneration.

Taxol damages hair growth cells, causing hair loss.

Scalp cooling does not stop hair loss from radiotherapy.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

DNA methylation of miR-365-1 causes hair follicle stem cell death by affecting DAP3.

Low-intensity ultrasound may help protect hair follicles from chemotherapy-induced hair loss.

Vitamins A, B, C, and D are important for skin health and are being explored for new uses, but more research is needed to confirm their effectiveness.

QR 678 and QR 678 Neo are safe and promote hair growth, potentially helping chemotherapy-induced hair loss.

Photobiomodulation can help regrow hair in certain types of hair loss.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

A new system was created to classify skin changes in cancer patients based on their treatment.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

A rare skin condition linked to leukemia improved with chemotherapy.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Prostaglandins may protect hair follicles during chemotherapy.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Feathers are useful for researching growth, regeneration, and the effects of treatments like chemotherapy on hair loss.

Scalp cooling prevented hair loss in half of the patients, despite significant side effects.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

Scalp cooling therapy is costly and often not covered by insurance, limiting access for low-income patients.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.